Royal Sense launches new product ‘Stergic Chikungunya IgG/IgM Rapid Test’

21 Aug 2024 Evaluate

Royal Sense has launched new product ‘Stergic Chikungunya IgG/IgM Rapid Test’ available for sale from August 21, 2024. The Chikungunya rapid test is a diagnostic tool designed to detect the presence of Chikungunya virus antibodies in a blood sample. This test is typically used to diagnose recent or current infections with Chikungunya virus, which is transmitted by mosquitoes and causes fever, joint pain, and other symptoms. 

The rapid test works by identifying specific antibodies produced by the immune system in response to the virus. Results are usually available within 15-20 minutes, making it a quick and efficient method for preliminary diagnosis. The test is valuable in areas where Chikungunya is prevalent, allowing for timely medical intervention. It is important to follow up with confirmatory testing and clinical evaluation for accurate diagnosis and treatment.

Royal Sense is suppliers of high quality goods that meet international standards required for hospitals, laboratories, institutions and clinics to provide health services.


Royal Sense Share Price

235.30 30.30 (14.78%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Redington 268.50
Adani Enterprises 2265.10
Amrapali Industries 15.02
Rashi Peripheral 325.05
PDS 339.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×